» Articles » PMID: 39863779

Global Metabolomic Alterations Associated with Endocrine-disrupting Chemicals Among Pregnant Individuals and Newborns

Abstract

Background: Gestational exposure to non-persistent endocrine-disrupting chemicals (EDCs) may be associated with adverse pregnancy outcomes. While many EDCs affect the endocrine system, their effects on endocrine-related metabolic pathways remain unclear. This study aims to explore the global metabolome changes associated with EDC biomarkers at delivery.

Methods: This study included 75 pregnant individuals who delivered at the University of Cincinnati Hospital from 2014 to 2017. We measured maternal urinary biomarkers of paraben/phenol (12), phthalate (13), and phthalate replacements (4) from the samples collected during the delivery visit. Global serum metabolome profiles were analyzed from maternal blood (n = 72) and newborn (n = 63) cord blood samples collected at delivery. Fifteen of the 29 urinary biomarkers were excluded due to low detection frequency or potential exposures during hospital stay. We assessed metabolome-wide associations between 14 maternal urinary biomarkers and maternal/newborn metabolome profiles. Additionally, performed enrichment analysis to identify potential alterations in metabolic pathways.

Results: We observed metabolome-wide associations between maternal urinary concentrations of phthalate metabolites (mono-isobutyl phthalate), phthalate replacements (mono-2-ethyl-5-carboxypentyl terephthalate, mono-2-ethyl-5-hydroxyhexyl terephthalate) and phenols (bisphenol-A, bisphenol-S) and maternal serum metabolome, using q-value < 0.2 as a threshold. Additionally, associations of phthalate metabolites (mono-n-butyl phthalate, monobenzyl phthalate) and phenols (2,5-dichlorophenol, BPA) with the newborn metabolome were noted. Enrichment analyses revealed associations (p-gamma < 0.05) with amino acid, carbohydrate, lipid, glycan, vitamin, and other cofactor metabolism pathways.

Conclusion: Maternal paraben, phenol, phthalate, and phthalate replacement biomarker concentrations at delivery were associated with maternal and newborn serum global metabolome.

References
1.
Vrijheid M, Slama R, Robinson O, Chatzi L, Coen M, van den Hazel P . The human early-life exposome (HELIX): project rationale and design. Environ Health Perspect. 2014; 122(6):535-44. PMC: 4048258. DOI: 10.1289/ehp.1307204. View

2.
Barr D, Wang R, Needham L . Biologic monitoring of exposure to environmental chemicals throughout the life stages: requirements and issues for consideration for the National Children's Study. Environ Health Perspect. 2005; 113(8):1083-91. PMC: 1280353. DOI: 10.1289/ehp.7617. View

3.
Ye X, Kuklenyik Z, Needham L, Calafat A . Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem. 2005; 77(16):5407-13. DOI: 10.1021/ac050390d. View

4.
Yu T, Park Y, Li S, Jones D . Hybrid feature detection and information accumulation using high-resolution LC-MS metabolomics data. J Proteome Res. 2013; 12(3):1419-27. PMC: 3624888. DOI: 10.1021/pr301053d. View

5.
Pollack A, Perkins N, Sjaarda L, Mumford S, Kannan K, Philippat C . Variability and exposure classification of urinary phenol and paraben metabolite concentrations in reproductive-aged women. Environ Res. 2016; 151:513-520. PMC: 5071150. DOI: 10.1016/j.envres.2016.08.016. View